• Embed Doc
  • Copy Link
  • Readcast
  • Collections
  • CommentGo Back
Download
 
VOLUME XIX NUMBER 3
MULTIDISCIPLINARY ASSOCIATION FOR PSYCHEDELIC STUDIES
2009 Annual Report
 
A ContinuingMedicalEducationConference
 
Psychedelic
SCIENCE
IN THE
Century
Twenty-frst
San Jose, CA
APRIL
 15
~
18
2010
Psychedelic Science in the 21st Century 
 A Continuing Medical Education (CME) Conference
with concurrent presentations in a non-CME track
For physicians, medical & therapeutic proessionals
and 
the general public.
 April 15-18, 2010 • San Jose, California
 
Presented by the Multidisciplinary Association for Psychedelic Studies (MAPS)
Featuring presentations by:
 co-founder of transpersonal psychology
Stanislav Grof, M.D.
 
consciousness researcher & psychotherapist
 
Ralph Metzner, Ph.D.
visionary artists
 Alex and Allyson Grey 
 founders of Erowid.org
Earth and Fire Erowid
 pharmacologist & chemist
 Alexander “Sasha” Shulgin, Ph.D.
 
integrative medicine proponent
 Andrew Weil, M.D.
 
Matt Baggott, Ph.D. Candidate, (UC Berkeley, LSD, MDMA, MDA, salvia divinorum researcher)
Jose Carlos Bouso, Ph.D. Candidate (Spain, MDMA/PTSD researcher)Alicia Danorth, Ph.D. Candidate (ITP, UCLA psilocybin researcher)Rick Doblin, Ph.D. (executive director & ounder o MAPS)Frank Echenhoer, Ph.D. (Caliornia Institute o Integral Studies)James Fadiman, Ph.D. (Institute o Transpersonal Psychology)Amanda Feilding, (Director o The Beckley Foundation)Peter Gasser, M.D. (Switzerland, LSD/end-o-lie anxiety researcher)Neal Goldsmith, Ph.D. (author, psychotherapist)Roland Grifths, Ph.D. (JHU, psilocybin/mystical experiences researcher)Charles Grob, M.D. (UCLA, psilocybin/cancer anxiety researcher)John Halpern, M.D.
by video link (Harvard, neurocognitive consequences of ecstasy researcher)
Julie Holland, M.D. (NYU School o Medicine, psychiatric emergency services)Sergio Marchevsky, M.D. (Israel, MDMA/PTSD researcher)John Mendelson, M.D. (CPMC RI, LSD, MDMA, MDA, salvia divinorum researcher)Michael Mithoeer, M.D. (U.S., MDMA/PTSD researcher)Francisco Moreno, M.D. (Psilocybin/OCD researcher)David Nichols, Ph.D. (Heter Research Institute, Purdue University)Peter Oehen, M.D. (Switzerland, MDMA/PTSD researcher)Ingrid Pacey, M.D. (Canada, MDMA/PTSD researcher)Torsten Passie, M.D., Ph.D. (Germany, psilocybin research)Tom Pinkson, Ph.D. (psychotherapist)Jordi Riba, Ph.D. (Spain, ayahuasca researcher)William Richards, Ph.D. (JHU, psilocybin/cancer anxiety researcher)Thomas Roberts, Ph.D. (Northern Illinois University)Stephen Ross, M.D. (NYU, psilocybin/cancer anxiety researcher)Ben Sessa, M.D. (UK, psilocybin researcher)Franz Vollenweider, M.D. (Switzerland, psychedelic neuroscience researcher)Michele Weitz, B.A. (U.S., clinical research expert)Others yet to be announced
Pre- and post-conference workshops with Alex & Allyson Grey, Stanislav Grof, M.D.,Rick Doblin, Ph.D., Michael Mithoefer, M.D., Annie Mithoefer, B.S.N. and others.
Information & registration:
www.maps.org/conference or call 831-429-6362
Presented by the Multidisciplinary Association for PsychedelicStudies (MAPS)
This activity has been planned and implemented in accordance with the Institute or Medical Quality and the Caliornia Medical Association’s CME Accreditation Standards (IMQ/CMA) through the Joint-Sponsorship o CME Consultants and theMultidisciplinary Association or Psychedelic Studies (MAPS). CME Consultants is accredited by IMQ/CMA to provide continuing medical education or physicians. CME Consultants takes responsibility or the content, quality and scientifc integrity o this CMEactivity.CME Consultants designates this educational activity or a maximum o 15.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent o their participation in the activity. This credit may also be applied to the CMA.
M
 A
PS
MULTIDISCIPLINARY ASSOCIATION FOR PSYCHEDELIC
 
maps • volume xix number 3 • winter 2oo9~1o
1
MAPS
(Multidisciplinary Association or PsychedelicStudies) is a membership-based organization. Founded in1986,
MAPS is an IRS approved 501 (c)(3) non-proftcorporation unded by tax deductible donations
.Our mission is 1) to treat conditions or which convention-al medicines provide limited relie—such as posttraumaticstress disorder (PTSD), pain, drug dependence, anxietyand depression associated with end-o-lie issues—bydeveloping psychedelics and marijuana into prescrip-tion medicines; 2) to cure many thousands o people bybuilding a network o clinics where treatments can beprovided; and 3) to educate the public honestly about therisks and benefts o psychedelics and marijuana.Interested parties wishing to copy any portion othis publication are encouraged to do so and are kindlyrequested to credit MAPS and include our address. TheMAPS Bulletin is produced by a small group o dedicatedsta and volunteers.
 Your participation, fnancial orotherwise, is welcome.
 2009 Multidisciplinary Associationfor Psychedelic Studies, Inc.MAPS309 Cedar Street, #2323, Santa Cruz, CA 95060Phone: 831-429-6362Fax: 831-429-6370E-mail: askmaps@maps.orgWeb: www.maps.org
Editor: Randolph Hencken, M.A.Design/Build: Noah Juan JuneauISSN 1080-8981Visit maps.org/catalog for informationabout donations and purchasesPrinted on recycled paper
Free Cultural Work - A Creative Commons Attribution
 You are ree: to share, to copy, distribute and transmitthis inormation under the ollowing conditions:
*Attribution
. You must attribute the work in themanner specifed by the author or licensor (but notin any way that suggests that they endorse youor your use o the work).
What does “Attribute this work” mean?
 * For any reuse or distribution, you must make clear toothers the license terms o this work. The best way todo this is with a link to our web page: www.maps.org* Any o the above conditions can be waived i youget permission rom the copyright holder.* Nothing in this license impairs or restricts theauthor’s moral rights. Your air dealing and other rights arein no way aected by the above.
1
CONTENTS Winter 2009
2
 Annual Financial Report
by Rick Doblin, Ph.D.15
MAPS’ Research: A Year in Review
by Valerie Mojeiko, B.A.18
Psychedelic Science in the 21st Century Conerence:
The PreeminentConerence on Psychedelic Research and Psychedelic Psychotherapyby Randolph Hencken, M.A.20
Psychedelic Outreach in the Inormation Age
by Brian Wallace22
O Prickles and Goo:
How MAPS is Redefning the Science o Spirituality
 
by Brad Burge, Ph.D. student24
Exploring the World o Ayahuasca-Based Tourism and the Globalization o Psychedelics:
 A Review o Two New Books rom Rak Razamby David Jay Brown, M.A.27
Who We Are:
MAPS Sta 28
Membership
page 
Covers:
See page 26 or descriptions and artists’ statments
In terms o our mission,FY 08-09 was ourbest year to date,MAPS gatheredsubstantially more datathan ever beore,and gained more experiencedesigning, obtaining approval or,unding, conducting,monitoring, and evaluatingpsychedelic psychotherapyclinical trials.
of 00

Leave a Comment

You must be to leave a comment.
Submit
Characters: ...
You must be to leave a comment.
Submit
Characters: ...